Loading companies…
Loading companies…
United Kingdom · Healthtech · AI · Biotech · Enterprise software
AI-driven continuous care platform for autoimmune disease and other complex chronic conditions
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5.4M | Oxford Science Enterprises — Role not disclosed |